LRP1B attenuates the migration of smooth muscle cells by reducing membrane localization of urokinase and PDGF receptors

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 8, 2004, Pages 1422-1428

  Tanaga, Kousei ^a   Bujo, Hideaki ^a   Zhu, Yanjuan ^a   Kanaki, Tatsuro ^a   Hirayama, Satoshi ^a,c   Takahashi, Kazuo ^a   Inoue, Masahiro ^b   Mikami, Keiji ^b   Schneider, Wolfgang J ^c   Saito, Yasushi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Omigawa Hospital   (Japan)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

LRP1B; Migration; PDGF receptor; Smooth muscle cells; uPA receptor

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MEMBRANE RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; UROKINASE RECEPTOR;

ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CELL TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE FIBER MEMBRANE;

AGED; AMINO ACID SEQUENCE; ANGINA, UNSTABLE; ANIMALS; CELL DIVISION; CELL MEMBRANE; CELL MOVEMENT; CELLS, CULTURED; CHICKENS; CORONARY VESSELS; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL INFARCTION; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, CELL SURFACE; RECEPTORS, LDL; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; TUNICA INTIMA;

EID: 3943050032     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000133607.80554.09     Document Type: Article

References (26)

1. Ross R. Atherosclerosis - An inflammatory Disease. N Engl J Med. 1999; 340:115-126.
2. Fuster V, Fayad ZA, Badimon JJ. Acute coronary syndromes: biology. Lancet. 1999;353:SII5-SII9.
3. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer. 1997;72:1-22.
4. Blasi F. Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system. Thromb Haemost. 1999;82: 298-304.
5. Ellis V. Plasminogen activation at the cell surface. Curr Top Dev Biol. 2003;54:263-312.
6. Biliran H Jr., Sheng S. Pleiotropic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive masfin. Cancer Res. 2001;61:8676-8682.
7. Silvestri I, Longanesi Cattani I, Franco P, Pirozzi G, Botti G, Stoppelli MP, Carriero MV. Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating α(v)β5 vitronectin receptor cell surface expression. Int J Cancer. 2002;102:562-571.
8. Nykjaer A, Conese M, Christensen EI, Olson D, Cremona O, Gliemann J, Blasi F. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J. 1997;16:2610-2620.
9. Weaver AM, Hussaini IM, Mazar A, Henkin J, Gonias SL. Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. J Biol Chem. 1997;272:14372-14379.
10. Nguyen DH, Webb DJ, Catling AD, Song Q, Dhakephalkar A, Weber MJ, Ravichandran KS, Gonias SL. Urokinase-type plasminogen activator stimulates the Ras/Extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and She. Rapid dissociation of GRB2/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells. J Biol Chem. 2000;275:19382-19388.
11. Zhu Y, Bujo H, Yamazaki H, Hirayama S, Kanaki T, Takahashi K, Shibasaki M, Schneider WJ, Saito Y. Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro. Circulation. 2002;105:1830-1836.
12. Zhu Y, Bujo H, Yamazaki H, Ohwaki K, Jiang M, Hirayama S, Kanaki T, Shibasaki M, Takahashi K, Schneider WJ, Saito Y. LR11, an LDL Receptor Gene Family Member, Is a Novel Regulator of Smooth Muscle Cell Migration. Circ Res. 2004;94:752-758.
13. Liu CX, Musco S, Lisitsina NM, Forgacs E, Minna JD, Lisitsyn NA. LRP-DIT, a putative endocytic receptor gene, is frequently inactivated in non-small cell lung cancer cell lines. Cancer Res. 2000;60:1961-1967.
14. Liu CX, Musco S, Lisitsina NM, Yaklichkin SY, Lisitsyn NA. Genomic organization of a new candidate tumor suppressor gene, LRP1B. Genomics. 2000;69:271-274.
15. Akita EM, Nakai S. Production and purification of Fab′ fragments from chicken egg yolk immunoglobulin Y (IgY). J Immunol Methods. 1993; 162:155-164.
16. Taira K. Bujo H, Hirayama S, Yamazaki H, Kanaki T, Takahashi K, Ishii I, Miida T, Schneider WJ, Saito Y. LR11, a mosaic LDL receptor family member, mediates the uptake of apo E-rich lipoproteins in vitro. Arterioscler Thromb Vasc Biol. 2001;21:1501-1506.
17. Yamazaki H, Bujo H, Kusunoki J, Seimiya K, Kanaki T, Morisaki N, Schneider WJ, Saito Y. Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member. J. Biol. Chem. 1996; 271:24761-24768.
18. Kanaki T, Bujo H, Hirayama S, Ishii I, Morisaki N, Schneider WJ, Saito Y. Expression of LR11, a mosaic LDL receptor family member, is markedly increased in atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1999;19:2687-2695.
19. Liu CX, Li Y, Obermoeller-McCormick LM, Schwartz AL, Bu G. The putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL receptor-related protein. J Biol Chem. 2001;276: 28889-28896.
20. Boucher P, Gotthardt M, Li WP, Anderson RG, Herz J. LRP: role in vascular wall integrity and protection from atherosclerosis. Science. 2003; 300:329-332.
21. Hiltunen TP, Luoma JS, Nikkari T, Ylä-Herttuala S. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions. Marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation. 1998;97:1079-1086.
22. Luoma JS, Hiltunen TP, Särkioja T, Moestrup SK, Gliemann J, Kodama T, Nikkari T, Ylä-Herttuala S. Expression of α2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest. 1994;93: 2014-2021.
23. Webb DJ, Nguyen DHD, Gonias SL. Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and Matrigel invasion. J Cell Sci. 2000;113:123-134.
24. Webb DJ, Nguyen DHD, Sankovic M, Gonias SL. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. J Biol Chem. 1999;274:7412-7420.
25. Ma Z, Thomas KS, Webb DJ, Moravec R, Salicioni AM, Mars WM, Gonias SL. Regulation of Rac1 activation by the low density lipoprotein receptor-related protein. J Cell Biol. 2002;159:1061-1070.
26. Li Y, Knisely JM, Lu W, McCormick LM, Wang J, Henkin J, Schwartz AL, Bu G. Low density lipoprotein (LDL) receptor-related protein 1B impairs urokinase receptor regeneration on the cell surface and inhibits cell migration. J Biol Chem. 2002;277:42366-42371.